(CercleFinance.com) – After having received in May from the European Commission a notice of intent to terminate the agreement on the supply of its candidate vaccine against Covid-19, Valneva indicates that it has submitted a remediation plan currently under discussion .
Some Member States have confirmed their interest in including an inactivated and adjuvanted whole virus vaccine solution, but the preliminary and not definitive volume indications received from Brussels would not be sufficient to ensure the sustainability of the programme.
“If these indications were confirmed, Valneva would not be able to conclude an amendment to the supply agreement for a reduction in the volumes ordered, and the European Commission would probably terminate the agreement”, warns the company.
She adds that the Committee for Medicinal Products for Human Use (CHMP) is expected to take a final vote on the marketing authorization application filed last month during the week of June 21.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
